AI assistant
Sending…
BOSTON SCIENTIFIC CORP — Director's Dealing 2019
Mar 7, 2019
29821_dirs_2019-03-07_22aad5e0-c386-4b34-9bc1-0ce4bee8b5b2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2019-03-06
Reporting Person: Pierce David A (EVP,Pres MedSurg)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-03-06 | Common Stock | S | 1357.0000 | $40.2500 | Disposed | 38940.0000 | Direct |
Footnotes
F1: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
More from BOSTON SCIENTIFIC CORP
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 8
Major Shareholding Notification
2026
May 6
Regulatory Filings
2026
May 5
Interim / Quarterly Report
2026
May 1
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 22
Regulatory Filings
2026
Apr 2